Ono Pharmaceutical
4528.T
#2076
Rank
$6.95 B
Marketcap
$14.80
Share price
-0.09%
Change (1 day)
-26.59%
Change (1 year)

P/E ratio for Ono Pharmaceutical (4528.T)

P/E ratio as of April 2024 (TTM): 8.71

According to Ono Pharmaceutical 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 8.71243. At the end of 2022 the company had a P/E ratio of 13.5.

P/E ratio history for Ono Pharmaceutical from 2009 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202213.5-30.32%
202119.4-7.07%
202020.8-0.88%
201921.0-5.27%
201822.2-11.2%
201725.0-10.94%
201628.1-92.59%
2015379-103.53%
2014< -1000-24124.25%
201344.7164.22%
201216.9-14.84%
201119.86.95%
201018.68.02%
200917.2

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.